Literature DB >> 7748461

Mitochondrial enzyme deficiencies in Down's syndrome.

J Prince1, S Jia, U Båve, G Annerén, L Oreland.   

Abstract

Defects in cytochrome oxidase (CO; complex 4) have recently been demonstrated in blood platelets and in brain tissue from patients with Alzheimer's disease (AD) with possible etiological implications. Because of pathogenetic similarities with AD, we have measured the activities of several mitochondrially localised enzymes in the blood platelets of individuals afflicted with trisomy-21 (Down's syndrome). The activities of monoamine oxidase, cytochrome oxidase, isocitrate dehydrogenase, and glutamate dehydrogenase were assayed in washed platelets from sixty caucasian, male and female control individuals (ages 18-60) and ten, young Down's Syndrome patients (ages 9-21). Significant reductions in the activities of monoamine oxidase, cytochrome oxidase, and isocitrate dehydrogenase were found. In all cases the average activities in Down's syndrome individuals were approximately two-thirds those of controls (DS/Controls = 0.68, 0.67, 0.64 respectively). The activity of the fourth enzyme studied, glutamate dehydrogenase, was found to be similar to controls. Results suggest that these reductions are a consequence of a generalised mitochondrial disturbance which may lie behind some pathogenetic aspect(s) of the disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7748461     DOI: 10.1007/BF02260938

Source DB:  PubMed          Journal:  J Neural Transm Park Dis Dement Sect        ISSN: 0936-3076


  17 in total

1.  Mitochondrial Factors and VACTERL Association-Related Congenital Malformations.

Authors:  S Siebel; B D Solomon
Journal:  Mol Syndromol       Date:  2013-02

2.  Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease.

Authors:  J P Sheehan; R H Swerdlow; S W Miller; R E Davis; J K Parks; W D Parker; J B Tuttle
Journal:  J Neurosci       Date:  1997-06-15       Impact factor: 6.167

3.  Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease.

Authors:  Fabio Di Domenico; Gilda Pupo; Antonella Tramutola; Alessandra Giorgi; Maria Eugenia Schininà; Raffaella Coccia; Elizabeth Head; D Allan Butterfield; Marzia Perluigi
Journal:  Free Radic Biol Med       Date:  2014-03-25       Impact factor: 7.376

4.  Oxygen uptake kinetics during exercise in adults with Down syndrome.

Authors:  Goncalo V Mendonca; Fernando D Pereira; Bo Fernhall
Journal:  Eur J Appl Physiol       Date:  2010-06-18       Impact factor: 3.078

5.  Down's syndrome and myocardial reperfusion injury.

Authors:  Susheel Kumar; Richard Jonas
Journal:  J Saudi Heart Assoc       Date:  2010-09-09

Review 6.  Neurodegenerative disorders associated with diabetes mellitus.

Authors:  Michael Ristow
Journal:  J Mol Med (Berl)       Date:  2004-06-03       Impact factor: 4.599

7.  Risk factors for the neurohumoral alterations underlying personality disturbances.

Authors:  Lars Oreland; Mattias Damberg; Jarmila Hallman; Cecilia Berggård; Hakan Garpenstrand
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

8.  Oxidative Stress and Down Syndrome: A Route toward Alzheimer-Like Dementia.

Authors:  Marzia Perluigi; D Allan Butterfield
Journal:  Curr Gerontol Geriatr Res       Date:  2011-11-29

9.  Lymphocyte respiration in children with Trisomy 21.

Authors:  Elhadi H Aburawi; Abdul-Kader Souid
Journal:  BMC Pediatr       Date:  2012-12-18       Impact factor: 2.125

10.  Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy.

Authors:  Anna Conti; Floriana Fabbrini; Paola D'Agostino; Rosa Negri; Dario Greco; Rita Genesio; Maria D'Armiento; Carlo Olla; Dario Paladini; Mariastella Zannini; Lucio Nitsch
Journal:  BMC Genomics       Date:  2007-08-07       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.